Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men
Sponsor: Duke University
This NA trial investigates Acquired Immunodeficiency Syndrome and HIV Infections and is currently completed. Duke University leads this study, which shows 11 recorded versions since 2021 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
11 versions recorded-
May 2025 — Present [monthly]
Completed NA
-
Sep 2024 — May 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
May 2023 — Sep 2023 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Mar 2023 — May 2023 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Nov 2022 — Mar 2023 [monthly]
Enrolling By Invitation NA
-
Jul 2022 — Nov 2022 [monthly]
Enrolling By Invitation NA
-
Sep 2021 — Jul 2022 [monthly]
Enrolling By Invitation NA
-
Jun 2021 — Sep 2021 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
Mar 2021 — Jun 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
- Impact Research & Development Organization
- Kenya Medical Research Institute
- National Institute of Mental Health (NIMH)
- University of California, San Francisco
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .